Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

908
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
908
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

201
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
201
Biological Causes of Schizophrenia01:29

Biological Causes of Schizophrenia

133
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
133
Psychological and Sociocultural Causes of Schizophrenia01:29

Psychological and Sociocultural Causes of Schizophrenia

179
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
179
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

435
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
435
Personality Disorders: Paranoid and Schizoid01:22

Personality Disorders: Paranoid and Schizoid

148
Personality disorders represent enduring cognition, affect, and behavior patterns that significantly deviate from societal norms. These maladaptive traits often lead to difficulties in various domains, including interpersonal relationships, occupational settings, and overall psychological well-being. Paranoid personality disorder and schizoid personality disorder are two distinct conditions marked by odd or eccentric behavior.
Paranoid Personality Disorder
Paranoid personality disorder is...
148

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of leucine-rich diet on placenta's proteomic and metabolomic profiles of pregnant tumor-bearing rats.

Cancer biology & therapy·2026
Same author

Unraveling the Antimicrobial and Antibiofilm Activity of Ag-phendione and Cu-phendione Against Multidrug-resistant Klebsiella pneumoniae Using Shotgun Proteomics.

Current topics in medicinal chemistry·2026
Same author

Editorial: The impact of proteomics on understanding inflammatory and infectious diseases.

Frontiers in immunology·2026
Same author

Engineering glyphosate tolerance in sugarcane through overexpression of a mutated version of its native <i>EPSPS</i> gene.

GM crops & food·2026
Same author

Plasma Proteomic Profile of Chemotherapy-Induced Severe Neutropenia: A Pilot Discovery Phase Study.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Same author

Hyperferritinemia and analytical challenges: can proteomics make the difference?

Clinical chemistry and laboratory medicine·2025
Same journal

Mammalian Respiratory Chain Complex Assemblies and Their Links to Mitochondria Stress-Induced Human Diseases.

Advances in experimental medicine and biology·2026
Same journal

Enzyme Assemblies in Nucleotide Metabolism: Structure, Regulation, and Disease Implications.

Advances in experimental medicine and biology·2026
Same journal

The Pyruvate Dehydrogenase Complex: A 90-Year-Old Enigma Shaping the Future of Structural Enzymology.

Advances in experimental medicine and biology·2026
Same journal

Regulation of the Anti-termination RNA Transcription Complex by Lon-Mediated Lambda N Degradation.

Advances in experimental medicine and biology·2026
Same journal

PCNA Macromolecular Complexes: PCNA Serves as a Molecular Hub Regulating Multiple Cellular Processes Inside and Outside of the Nucleus.

Advances in experimental medicine and biology·2026
Same journal

Dynamic Assemblies in Genome Maintenance.

Advances in experimental medicine and biology·2026
See all related articles

Related Experiment Video

Updated: Aug 30, 2025

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

14.0K

PTMs: A Missing Piece for Schizophrenia Studies.

Caroline Brandão-Teles1, Bradley J Smith1, Victor Corasolla Carregari2

  • 1Laboratory of Neuroproteomics, Department of Biochemistry and Tissue Biology, Institute of Biology, University of Campinas (UNICAMP), Campinas, SP, Brazil.

Advances in Experimental Medicine and Biology
|August 27, 2022
PubMed
Summary
This summary is machine-generated.

Post-translational modifications (PTMs) are key to cellular function and offer insights into schizophrenia. Further PTMomics research is crucial for understanding this complex disorder and developing new treatments.

Keywords:
Post-translational modificationsProteomicsSchizophrenia

More Related Videos

Utilizing Transcranial Magnetic Stimulation to Study the Human Neuromuscular System
12:19

Utilizing Transcranial Magnetic Stimulation to Study the Human Neuromuscular System

Published on: January 20, 2012

27.1K
The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.1K

Related Experiment Videos

Last Updated: Aug 30, 2025

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

14.0K
Utilizing Transcranial Magnetic Stimulation to Study the Human Neuromuscular System
12:19

Utilizing Transcranial Magnetic Stimulation to Study the Human Neuromuscular System

Published on: January 20, 2012

27.1K
The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.1K

Area of Science:

  • Biochemistry and Molecular Biology
  • Neuroscience
  • Genetics

Background:

  • Post-translational modifications (PTMs) are crucial regulatory mechanisms influencing protein function and cellular phenotypes.
  • PTMs represent a promising avenue for understanding complex multifactorial diseases like schizophrenia.
  • The field of PTMomics is rapidly evolving, with growing evidence linking specific PTMs to schizophrenia's etiology and treatment.

Purpose of the Study:

  • To review and present well-supported arguments for the dysregulation of PTMs in schizophrenia.
  • To highlight the potential of PTMomics in advancing schizophrenia research.
  • To identify areas for future investigation into the role of various PTMs in schizophrenia.

Main Methods:

  • Literature review and synthesis of existing research on PTMs and schizophrenia.
  • Analysis of current evidence implicating specific PTMs in the disease.
  • Discussion of the broader implications of PTM dysregulation.

Main Results:

  • Several PTMs have been significantly implicated in the development and progression of schizophrenia.
  • Dysregulation of PTMs is a recurring theme in the pathophysiology of schizophrenia.
  • The vast number of potential PTMs suggests many modifications remain to be discovered in relation to schizophrenia.

Conclusions:

  • PTM dysregulation is a critical factor in schizophrenia, offering new perspectives for research.
  • Continued exploration in PTMomics is essential for a comprehensive understanding of schizophrenia.
  • Further studies are warranted to elucidate the specific roles of various PTMs in schizophrenia and their therapeutic potential.